Publications

Pillsbury A, Phillips A, Deng L, Quinn H, Macartney K, Gidding H. Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines. Vaccine 2023:S0264-410X:00441-3. doi: 10.1016/j.vaccine.2023.04.041. (Epub). [Full text]

Koirala A, Winkler NE, Quinn HE, Gardiner E, Liu B, Forbes J, Sharpe C, van Tussenbroek T, Wood N, Macartney K . Understanding SARS-CoV-2 Delta and Omicron variant transmission and vaccine impact in schools and child-care settings in Australia: a population-based study. The Lancet Regional Health - Western Pacific 2023;35:100736. doi: 10.1016/j.lanwpc.2023.100736. [Full text]

Jayasinghe S, Patel C, Armstrong L, Chiu C, Macartney K, Flanagan K, Gibney K, Giles M, Crawford N, Cheng A, Blyth C. ATAGI Targeted Review 2021: the national COVID-19 vaccination program. Commun Dis Intell (2018). 2023;47. doi: 10.33321/cdi.2023.47.20. [Full text]

Huang YA, Li-Kim-Moy J, Jayasinghe S, Chiu C, Macartney K, Liu B, Burns P, Giles M, Crawford N. ATAGI Targeted Review 2022: Vaccination for prevention of herpes zoster in Australia. Commun Dis Intell (2018). 2023;47. doi: 10.33321/cdi.2023.47.21. [Full text]

Arkell P, Sheridan SL, Martins N, Tanesi MY, Gomes N, Amaral S, Oakley T, Solano V, David M, Draper AD, Sarmento N, da Silva E, Alves L, Freitas C, de Neri Machado F, Gusmão CA, da Costa Barreto I, Fancourt NS, Macartney K, Yan J, Francis JR. Vaccine preventable disease seroprevalence in a nationwide assessment of Timor-Leste (VASINA-TL) - study protocol for a population-representative cross-sectional serosurvey. BMJ 2022. doi: 10.1101/2022.12.23.22283897 . [Full text]

Basseal JM, Bennett CM, Collignon P, Currie BJ, Durrheim DN, Leask J, McBryde ES, McIntyre P, Russell FM, Smith DW, Sorrell TC, Marais BJ. Key lessons from the COVID-19 public health response in Australia. The Lancet Regional Health Western Pacific 2023;30:100616. doi: 10.1016/j.lanwpc.2022.100616. [Full text]

Kermond RF, Ozimek-Kulik JE, Kim S, Alexander SI, Hahn D, Kesson A, Wood N, McCarthy HJ, Durkan AM. Immunologic response to SARS-CoV-2 mRNA vaccination in pediatric kidney transplant recipients. Pediatric Nephrology 2023;38:859-866. doi: 10.1007/s00467-022-05679-y. [Full text]

Khoo WH, Jackson K, Phetsouphanh C, Zaunders JJ, Alquicira-Hernandez J, Yazar S, Ruiz-Diaz S, Singh M, Dhenni R, Kyaw W, Tea F, Merheb V, Lee FXZ, Burrell R, Howard-Jones A, Koirala A, Zhou L, Yuksel A, Catchpoole DR, Lai CL, Vitagliano TL, Rouet R, Christ D, Tang B, West NP, George S, Gerrard J, Croucher PI, Kelleher AD, Goodnow CG, Sprent JD, Powell JE, Brilot F, Nanan R, Hsu PS, Deenick EK, Britton PN, Phan TG. Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19. Clinical Immunology 2023;246:109209. doi: 10.1016/j.clim.2022.109209

. [Full text]

Ong N, Brogan D, Lucien A, Wolman S, Campbell D, Deng L, Koirala A, Garg P, Sharma K. The development and evaluation of a vaccination pathway for children with intellectual and developmental disability and needle fear. Paediatric Neonatal Pain 2023:1-9. doi: 10.1002/pne2.12103. [Full text]

Niha MA, Draper AD, da Silva Viegas O, de Araujo RM, Joao JC, da Silva E, Barreto I, Sarmento N, Oakley T, de Neri Machado F, Fancourt NS, Marr I, dos Santos Fernandes LN, Martins N, Arkell P, Tilman AJ, Dingle B, Freitas CC, Bhowmick PS, Sheridan S, Howd. The epidemiology of the COVID-19 pandemic in the small, low-resource country of Timor-Leste, January 2020 – June 2022. Communicable Diseases Intelligence (2018) 2023;47. doi: 10.33321/cdi.2023.47.1. [Full text]